www.Cancer.gov News Releases

February 20, 2011 by  
Filed under Cancer in the news

  1. Immunotherapy drug improves outcomes for some children with relapsed leukemia - For children and young adults with certain relapsed B-cell acute lymphoblastic leukemia (B-ALL), the immunotherapy drug blinatumomab is superior to standard chemotherapy, an NCI-sponsored Children’s Oncology Group trial shows.
  2. Study quantifies impact of NCI-sponsored trials on clinical cancer care - Nearly half of phase 3 cancer clinical trials carried out by the NCI-sponsored SWOG Cancer Research Network were associated with clinical care guidelines or new drug approvals, a study in JAMA Network Open shows.
  3. NCI study finds long-term increased risk of cancer death following common treatment for hyperthyroidism - Findings from a new NCI study of patients who received radioactive iodine (RAI) treatment for hyperthyroidism show an association between the dose of treatment and long-term risk of death from solid cancers, including breast cancer.
  4. Annual Report to the Nation: Overall cancer mortality continues to decline; Special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men - The 2019 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline and cancer incidence dropped in men and remained stable in women. A special section reports on recent cancer trends in younger adults.
  5. Study shows incidence rates of aggressive subtypes of uterine cancer rising - An NCI-led study shows rates for aggressive subtypes of uterine cancer rose rapidly among women ages 30 to 79 from 2000–2015. The findings, published in the Journal of Clinical Oncology, also reveal racial disparities in incidence and survival rates.
  6. Harnessing T-cell “stemness” could enhance cancer immunotherapy - A new study provides insight into how cancer immunotherapy works and suggests ways to enhance the treatment’s effectiveness. The NCI-led study, published in Science, examined the effect of high potassium levels on T cells.
  7. Szent-Györgyi Prize to honor NCI’s Steven A. Rosenberg - The 2019 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to NCI’s Steven A. Rosenberg, M.D., Ph.D., for his pioneering role in the development of immunotherapy.
  8. AI approach outperformed human experts in identifying cervical precancer - A research team from NIH and Global Good has developed a computer algorithm that can analyze digital images of the cervix and identify precancerous changes that require medical attention. The AI approach could be valuable in low-resource settings.
  9. BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk - The BRCA Exchange, a global resource that includes data on thousands of inherited variants in the BRCA1/BRCA2 genes, is available to the public through a website and new smartphone app.
  10. Study finds elevated risk of certain rare blood cancers after chemotherapy for most solid tumors - In a new study, NIH investigators found that patients treated with chemotherapy for most solid tumors had an increased risk of tMDS/AML, a rare but often fatal blood cancer. The study, which used population-based data, was published in JAMA Oncology.
Enter Google AdSense Code Here


Comments are closed.